Accenture plc (ACN - Free Report) is one of world’s leading providers of management consultancy, technology and outsourcing services. The company is steadily gaining traction in its outsourcing business primarily backed by a rise in demand for technology to improve operating efficiencies and save costs.
Furthermore, considering the growing need for digital marketing, we commend Accenture’s efforts to enhance its digital marketing capabilities through acquisitions which should positively impact first-quarter results.
However, increasing competition from Cognizant Technology Solutions and International Business may temper its growth prospects to some extent. Additionally, Accenture’s plan of creating 15K new jobs in the U.S. by 2020 and investment of $1.4 billion for employee training and opening of 10 innovation centers across the U.S. cities may dent its bottom-line results in our opinion.
Accenture have a decent history when it comes to recent earnings reports as the stock has beaten estimates in all the last four quarters, making for an average surprise of approximately 2.6%. Currently, Accenture has a Zacks Rank #2 (Buy).
We have highlighted some of the key stats from this just-revealed announcement below:
Earnings: Accenture beats on earnings. The Zacks Consensus Estimate called for EPS of $1.66 per share, and the company reported non-GAAP EPS of $1.79 per share.
Revenue: Revenues surpassed. Accenture posted revenues of $9.523 billion, compared to the Zacks Consensus Estimate of $9.244 billion.
Key Stats: The company witnessed year-over-year growth in revenue, primarily aided by an increase in Consulting and Outsourcing revenues.
2Q18 Outlook: For 2Q18, Accenture expects revenue to be in the range of $9.15 billion to $9.40 billion.
Check back later for our full write up on this Accenture earnings report later! You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks’ Best Private Investment Ideas
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.
Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors.
Click here for Zacks' private trades >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Accenture plc (ACN - Free Report) is one of world’s leading providers of management consultancy, technology and outsourcing services. The company is steadily gaining traction in its outsourcing business primarily backed by a rise in demand for technology to improve operating efficiencies and save costs.
Furthermore, considering the growing need for digital marketing, we commend Accenture’s efforts to enhance its digital marketing capabilities through acquisitions which should positively impact first-quarter results.
However, increasing competition from Cognizant Technology Solutions and International Business may temper its growth prospects to some extent. Additionally, Accenture’s plan of creating 15K new jobs in the U.S. by 2020 and investment of $1.4 billion for employee training and opening of 10 innovation centers across the U.S. cities may dent its bottom-line results in our opinion.
Accenture have a decent history when it comes to recent earnings reports as the stock has beaten estimates in all the last four quarters, making for an average surprise of approximately 2.6%. Currently, Accenture has a Zacks Rank #2 (Buy).
We have highlighted some of the key stats from this just-revealed announcement below:
Earnings: Accenture beats on earnings. The Zacks Consensus Estimate called for EPS of $1.66 per share, and the company reported non-GAAP EPS of $1.79 per share.
Revenue: Revenues surpassed. Accenture posted revenues of $9.523 billion, compared to the Zacks Consensus Estimate of $9.244 billion.
Key Stats: The company witnessed year-over-year growth in revenue, primarily aided by an increase in Consulting and Outsourcing revenues.
2Q18 Outlook: For 2Q18, Accenture expects revenue to be in the range of $9.15 billion to $9.40 billion.
Check back later for our full write up on this Accenture earnings report later! You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks’ Best Private Investment Ideas
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.
Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors.
Click here for Zacks' private trades >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ACN - FREE